Disruptive Pharma
We develop selected drug products based on our proprietary drug delivery platform, the pharma-grade mesoporous magnesium carbonate (Pharma MMC).
By a clever amorphous formulation of already approved active pharmaceutical ingredients (APIs) or new chemical entities (NCEs) into Pharma MMC platform we can realize novel and safe improved or therapeutically equivalent drug products.
Our goal is to maximize the potential of the Company by harnessing the potential of our continuously expanding pool of high-performing, safe and IP-protected drug products based on Pharma MMC.